Pediatric
Efferon NEO
The first CE‑marked single-use multimodal extracorporeal blood purification device ever purpose‑built to treat pediatric sepsis and septic shock.
Intended use
The device is intended for extracorporeal blood purification via an extracorporeal circuit. It can be performed as isolated hemoadsorption mode or in combination with RRT, ECMO and CPB. Inflammatory mediators and endotoxin are removed from patients' circulation. Timely administration improves vital functions and hinders progression of multiple organ failure in sepsis patients.
Common risks
- Hypovolemia
- Bleeding
- Catheter infection
- Air embolism
- Individual intolerance
- Hemolysis
- Increased clearance of drugs
- Decrease in platelets count
- Premature circuit clotting
Potential side effects
- Short-term hemodynamic disorders
- Risks associated with anticoagulation
- Unintended removal of other blood substances
- Hemolysis
- Thrombocytopenia, leukopenia
- Clotting in the extracorporeal circuit
- Blood loss and air embolism
- Risks related to vascular access placement